Some of the most effective therapies available today are not commercially distributed in the United States, or are available only at prohibitive prices. For patients facing cancer or a rare disease, this can mean waiting for a treatment that exists, but remains out of reach. New Imports was created to close that gap.
We specialize in the import advisory of oncology medications, including targeted therapies, immunotherapies, and biologics used across a wide range of cancer protocols. Because these treatments are often time-sensitive, we coordinate every stage, from sourcing and documentation to temperature-controlled logistics, to help ensure continuity of care without unnecessary delay.
We also support patients living with rare and high-cost conditions, where approved therapies may be scarce, recently launched abroad, or simply unavailable through conventional channels. By sourcing from certified distributors in Europe and the Americas, we provide access to medications that might otherwise require traveling overseas, frequently at more accessible prices than the domestic market.
Our service is dedicated exclusively to individual patients. We do not import on behalf of clinics, hospitals, or healthcare institutions. Every import is arranged directly for the person under treatment, based on a valid medical prescription and in full compliance with FDA regulations and the laws of each country of origin.
We are not a pharmacy, manufacturer, or distributor. Our role is to advise, coordinate, and safeguard the integrity of your treatment from origin to delivery.